Lung Cancer Journal Articles

• The Oncogenic Landscape of the IPF: A Narrative Review Recent advances have helped further our understanding of the link between idiopathic pulmonary fibrosis and lung cancer, contributing to improvements in diagnosis and treatment.
  Translational Lung Cancer Research, May 23, 2022
• Comorbidities and Co-Medications Among People With HIV How prevalent are comorbidities and the use of non-ART co-medications among people living with HIV?
  HIV Medicine, May 19, 2022
• Safety of IV Golimumab in RA, PsA, and AS A pooled analysis of data from three trials provides insight into the safety profile of IV golimumab for the treatment of these rheumatologic conditions.
  Arthritis Research & Therapy, May 18, 2022
• Cancer Screening Prevalence and Associated Factors This editorial highlights cancer screening trends, the importance of cancer screening, and the many factors which can affect cancer screening behavior.
  Preventing Chronic Disease, May 18, 2022
• Recurrent ICI-Related Pneumonitis in Lung Cancer Patients Pneumonitis is a known complication associated with immune checkpoint inhibitor treatment. How often do recurrent episodes occur in lung cancer patients, and what are the risk factors?
  Translational Lung Cancer Research, May 09, 2022
• COVID-19 Pandemic Impacts on Treatment for Metastatic Cancer The COVID-19 pandemic has resulted in delays and disruptions in health care. Has it similarly affected the treatment of patients with metastatic cancer?
  Journal of the National Cancer Institute, May 04, 2022
• Neoadjuvant Immunotherapy or Chemoimmunotherapy in NSCLC How do these treatments for non-small cell lung cancer compare? Is one more beneficial than the other?
  Translational Lung Cancer Research, May 02, 2022
• Distant Metastatic Patterns and Prognosis in Thyroid Cancer Gain a better understanding of the relationship between clinicopathologic factors and metastatic patterns and the prognostic impacts in differentiated thyroid cancer.
  Clinical Endocrinology, April 14, 2022
• Outcomes of Thyroid Cancer With Excellent Treatment Response Thyroid cancer patients who had an excellent response to treatment may be at a low risk for recurrence. Is it time to reconsider lifelong follow-up of these patients?
  Clinical Endocrinology, April 07, 2022
• Safety and Efficacy of Nivolumab Plus Endostatin in NSCLC This combination therapy shows promise as a potential safe and effective option for advanced NSCLC patients who did not adequately respond to previous treatment.
  Translational Lung Cancer Research, April 01, 2022
• Alcohol, Smoking, Drug Use and HIV Virological Outcomes Might alcohol, cigarette and drug use impact ART adherence and virological outcomes among people living with HIV?
  HIV Medicine, March 17, 2022
• E-Cigarettes and Cardiopulmonary Health This review summarizes what we currently know about the impact of e-cigarettes and vaping on cardiopulmonary health, but there are many unanswered questions.
  Circulation, March 14, 2022
• Pembrolizumab for Bone Metastases in Advanced NSCLC Pembrolizumab therapy, either alone or in combination, may be an effective treatment option for bone metastases in non-small cell lung cancer patients.
  Translational Lung Cancer Research, March 14, 2022
• The BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients Is the SARS-CoV-2 BNT162b2 vaccine safe and effective in cancer patients receiving active treatment?
  Journal of the National Cancer Institute, March 09, 2022
• Safety and Efficacy of Tofacitinib for Ulcerative Colitis This paper presents final data from OCTAVE Open, an open-label, long-term extension study on the safety and efficacy of the Janus kinase inhibitor tofacitinib for the treatment of ulcerative colitis.
  Alimentary Pharmacology & Therapeutics, March 08, 2022
• Procalcitonin and Prognosis in Small Cell Lung Cancer What could procalcitonin levels tell us about the prognosis of small cell lung cancer patients?
  Translational Lung Cancer Research, February 28, 2022
• Headache Neuroimaging: Current Practice and Barriers Is neuroimaging overused for patients with headache? This survey aimed to better understand current practice, clinician understanding and attitudes, and barriers to optimal headache neuroimaging.
  Headache, February 17, 2022
• Histopathology in Transbronchial Biopsy, Autopsy in COVID-19 This comparison of pre- and postmortem pathological findings in paired lung biopsies and autopsy samples in patients with COVID-19 elucidates early pathologic changes and progression of disease.
  American Journal of Clinical Pathology, February 11, 2022
• Afatinib as First-Line Therapy for Advanced EGFR NSCLC Real-world data supports the safety and efficacy of afatinib in patients with EGFR mutation-positive NSCLC.
  Translational Lung Cancer Research, February 11, 2022
• Use of Adjuvant Chemotherapy in Resected NSCLC Do the benefits of adjuvant chemotherapy in resected NSCLC seen in clinical trials translate to real-life practice?
  Translational Lung Cancer Research, January 28, 2022